Jasper Therapeutics (JSPR) PT Lowered to $60 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts JSPR Hot Sheet
Price: $0.72 +4.35%
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
H.C. Wainwright analyst Emily Bodnar lowered the price target on Jasper Therapeutics (NASDAQ: JSPR) to $60.00 (from $65.00) while maintaining a Buy rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Jasper Therapeutics (JSPR)
- Agilent (A) PT Raised to $150 at Jefferies
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
